Anti-VSIG2 antibodies are used in the immunodetection of the protein V-set and immunoglobulin domain containing 2. In humans, the canonical protein has a reported length of 327 amino acid residues and a mass of 34.3 kDa. Its subcellular localization is in the membrane. Up to 2 different isoforms have been reported for this protein. It is reported to be highly expressed in the stomach, colon, prostate, trachea and thyroid glands and weakly in bladder and lung. VSIG2 is known to be involved with the metabolism of lipids. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include CTH, CTXL, V-set and immunoglobulin domain-containing protein 2, CT-like protein, cortical thymocyte receptor (X. laevis CTX) like, and 2210413P10Rik. VSIG2 gene orthologs have been reported in the mouse, rat, bovine, frog and chimpanzee species. Western Blot is the most common application for the VSIG2 antibodies listed below. Flow Cytometry and Immunohistochemistry are also common applications.